发明名称 COMPOSICION FARMACEUTICA QUE COMPRENDE UN COMPUESTO DERIVADO DE ACIDO CARBOXILICO, UNO O MAS COMPUESTOS TERAPEUTICAMENTE ACTIVOS Y UN DILUYENTE FARMACOLOGICAMENTE ACEPTABLE; Y SU USO PARA TRATAR UNA ENFERMEDAD INFLAMATORIA.
摘要 A composition, method and kit comprising a compound for the inhibition of the binding of alpha<SUB>4</SUB>beta<SUB>1 </SUB>integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin and other therapeutic compounds for the control or prevention of diseases states in which alpha<SUB>4</SUB>beta<SUB>1 </SUB>is involved.
申请公布号 CL2003002292(A1) 申请公布日期 2005.01.21
申请号 CL20030002292 申请日期 2003.11.07
申请人 ENCYSIVE PHARMACEUTICALS INC., SCHERING CORPORATION 发明人 VANDERSLICE PETER, HOLLAND GEORGE, SHIH NENG-YANG, ASLANIAN ROBERT G. CHAPMAN RICHARD, KREUTNER WILLIAM
分类号 A61K;A61K31/4375;A61K31/44;A61K31/50;A61K31/505;A61P9/10;A61P11/06;A61P17/06;A61P19/00;C07D239/47;(IPC1-7):A61K31/437 主分类号 A61K
代理机构 代理人
主权项
地址